12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Prevention
Session:
Chronic coronary syndromes: pathophysiology, treatment, and prognosis